Bank of Nova Scotia
ABBV icon

Bank of Nova Scotia’s AbbVie ABBV Stock Holding History

Bank of Nova Scotia’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-340
Closed -$77.7K – 1075
2025
Q4 		$77.7K Hold
340
– – ﹤0.01% 1065
2025
Q3 		$78.7K Hold
340
– – ﹤0.01% 1009
2025
Q2 		$63.1K Hold
340
– – ﹤0.01% 972
2025
Q1 		$71.2K Hold
340
– – ﹤0.01% 977
2024
Q4 		$60.4K Sell
340
-110
-24% -$20.2K ﹤0.01% 1004
2024
Q3 		$88.9K Hold
450
– – ﹤0.01% 954
2024
Q2 		$77.2K Hold
450
– – ﹤0.01% 963
2024
Q1 		$81.9K Buy
+450
New +$77.6K ﹤0.01% 981

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of Nova Scotia's ABBV Position: Q1 2026 in Review

Bank of Nova Scotia reduced its AbbVie (ABBV) stake by 54% in Q1 2026, selling an estimated $85.7M and leaving 330,712 shares worth $71.9M. The position accounts for 0.13% of the portfolio, ranked #137.

Bank of Nova Scotia first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $188M in Q1 2023. 4,087 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Bank of Nova Scotia held 330,712 shares of AbbVie worth $71.9M as of Q1 2026.
  • Bank of Nova Scotia sold 386,275 AbbVie shares in Q1 2026, an estimated $85.7M.
  • AbbVie made up 0.13% of Bank of Nova Scotia's portfolio in Q1 2026, its #137 holding.
  • Bank of Nova Scotia first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Bank of Nova Scotia's AbbVie position peaked at $188M in Q1 2023.
  • 4,087 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.